Robert Orlowski, Deputy Chair of Lymphoma/Myeloma, Vice Chair of MM Research, and Florence Maude Thomas Cancer Research Professor at the University of Texas MD Anderson Cancer Center, shared a post on X:
“Myeloma Paper of the Day:
SEER-Medicare analysis of treatment patterns for pts w/ initial dx of smoldering myeloma in US finds % of patients who received treatments increased from 2013 to 2014 and from 2016 to 2017, w/ IMiD-based tx most common.”
Title: Treatment patterns for patients with initial diagnosis of smoldering multiple myeloma in the United States: a SEER-Medicare analysis
Authors: Rong Wang, Sylvia H. Hsu, Natalia Neparidze, Martin W. Schoen, Su-Hsin Chang, Shi-Yi Wang
You can read the Full Article on Haematologica.
You can find other articles featuring Robert Orlowski on OncoDaily.
